Paul M. Ryther, Attorney at Law

Paul M. Ryther, Attorney at Law **Attorney Advertising**

Practicing Elder Law, Trust & Estate Planning and Administration, and Social Security Benefits Law Call for an appointment !

Connect with me on LinkedIn at www.linkedin.com/pub/paul-m-ryther/61/665/67

Please see my web site for more information.

04/03/2023

With an acronym that imho approaches the bounds of offensiveness, SSA announced in Fed. Reg. Vol. 88, No. 62 (Friday, March 31, 2023), pp. 19339-19340, available online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2023-06706] --

https://www.govinfo.gov/content/pkg/FR-2023-03-31/html/2023-06706.htm
https://www.govinfo.gov/content/pkg/FR-2023-03-31/pdf/2023-06706.pdf

"a demonstration project for the Social Security Supplemental Security Income (SSI) program under title XVI of the Social Security Act (Act). In this project, we will test the effect of providing guaranteed income to adults with cancer in active treatment . . ."

This experiment, which will run from March, 2023, through April, 2030, will pay $1,000 per month for 12 months to randomly selected individuals in New Jersey and Pennsylvania. "The control group consists of participants who will not receive guaranteed income payments; they will receive the typical supports available to patients with cancer at their hospital, including a referral to a social worker or navigator. The intervention group consists of participants who will receive guaranteed income payments of $1,000 per month for 12 months, along with benefits counseling." All participants must have income at or below 200% of the Federal Poverty Line [$29,160 annual income for a single person, $39,440 for a couple in 2023]. Intervention group participants who receive SSI will benefit from having the guaranteed income payments excluded from income, and from resources for "up to three years after receipt of the final guaranteed income payment", and from deeming of both income and resources.

For more detail, please see the announcement in the Federal Register.

Now, if maybe they'd attend to increasing, to a reasonable and humane amount, the punitively low resource limit for all SSI recipients, that might be something actually beneficial and probably wouldn't cost the program a dime. But I digress.

-p-

06/29/2022

The Social Security Administration gets right to the heart of the matter today. Announced in Fed. Reg., Vol. 87, No. 124 (Wednesday, June 29, 2022), pp. 38838-38867, available online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2022-12980] --

https://www.govinfo.gov/content/pkg/FR-2022-06-29/html/2022-12980.htm
https://www.govinfo.gov/content/pkg/FR-2022-06-29/pdf/2022-12980.pdf

SSA proposes "to revise some of the criteria in the Listing of Impairments (listings) that we use to evaluate claims involving cardiovascular disorders in adults and children under titles II and XVI of the Social Security Act (Act). The proposed revisions reflect advances in medical knowledge, our adjudicative experience, and comments we received from experts and the public in response to an advance notice of proposed rulemaking (ANPRM), and at an outreach policy conference.

"DATES: To ensure that your comments are considered, we must receive them by no later than August 29, 2022. . . ."

Please see the announcement itself for instructions for submission of comments.

Last revised effective April 13, 2006, announced January 13, 2006, with effective date most recently extended to February 6, 2026, the move to re-revise these Listings began a mere 2 years later with an Advance Notice of Proposed Rulemaking. That led to a variety of meetings, studies, conferences and reviews which now have advanced to the Notice of Proposed Rulemaking published today.

The first change people will notice, assuming the proposed changes are adopted, is a change in the name from
Cardiovascular System
to
Cardiovascular Disorders

As has been the Administration's wont over the past few years, these proposed revisions exhibit a further shift away from purely medical findings to assessing impact on ability to function, allowing an additional degree of both medical source and adjudicator subjectivity to creep into the analysis at Step 3 of the sequential evaluation process.

The introductory text of sections 4.00 and 104.00, which contain definitions and other explanations, gets a significant makeover, and "editorial" changes are made throughout the proposed revisions. Substantive changes to the various impairments in this Listing are described as --

- remove Listing 104.13, rheumatic heart disease, without renumbering succeeding sections
- add Listings 4.16 & 104.16 for cardiac allograft vasculopathy
- add Listing 4.07 for aortic valvular disease
- add Listing 4.08 for cardiomyopathy
- revise Listings 4.02 and 104.02 for chronic heart failure
- revise Listing 4.04 for ischemic heart disease (IHD)
- revise Listings 4.05 and 104.05 for recurrent arrhythmias
- revise Listing 4.06 for symptomatic congenital heart disease
- revise Listing 104.06 for congenital heart disease
- revise Listings 4.09 and 104.09 for heart transplant
- revise Listing 4.11 for chronic venous insufficiency, and
- revise Listing 4.12 for peripheral arterial disease

The proposed changes are not a total revision but are extensive, and with a Listing as large as this one is they are too vast to be summarized here. As you know, gentle reader, there is no substitute for direct familiarity with the authoritative material, and in this case you are very lucky, because the announcement in the Fed. Reg. includes charts and tables (best formatted for viewing in the PDF version) showing comparisons of new with old and describing the changes, as well as, of course, the full text of the proposed revisions themselves.

Happy reading!

-p-

05/17/2022

SSA has loosened up the standard it applies in order to find that a claim for benefits is tainted by "fraud or similar fault" (FSF).

Announced in today's Fed. Reg., Vol. 87, No. 95 (Tuesday, May 17, 2022), pp. 29995-29998, and pp. 29993-29995, available online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2022-10558] --

https://www.govinfo.gov/content/pkg/FR-2022-05-17/html/2022-10559.htm
https://www.govinfo.gov/content/pkg/FR-2022-05-17/pdf/2022-10559.pdf

and

https://www.govinfo.gov/content/pkg/FR-2022-05-17/html/2022-10558.htm
https://www.govinfo.gov/content/pkg/FR-2022-05-17/pdf/2022-10558.pdf

SSA is rescinding SSR 16-1p and SSR 16-2p, both issued effective March 14, 2016, and replaces them with SSR 22-1p and SSR 22-2p, both effective today.

1p's title is "Titles II and XVI: Fraud and Similar Fault Redeterminations Under Sections 205(u) and 1631(e)(7) of the Social Security Act" and 2p is "Titles II and XVI: Evaluation of
Claims Involving the Issue of Similar Fault in the Providing of
Evidence", in both versions.

As an aside, these SSRs probably should be reviewed with an eye to SSA's "bad doctor" regulations, 20 CFR sec.s 1503b and 416.903b.

Advocates may find this revision to be a dangerous erosion of claimants' rights. The statue, 42 USC sec.s 405(u) and 1383(e)(7), requires SSA to disregard any evidence provided for determining entitlement to Title II benefits or eligibility for Title XVI benefits that is tainted by fraud or similar fault (known affectionately to some as "FSF"). Fraud is not defined in the statute, but "similar fault" is involved if either "an incorrect or incomplete statement that is material to the determination is knowingly made", or "information that is material to the determination is knowingly concealed".

The administrative standard until today has been that a "finding of similar fault can be made only if there is reason to believe that, based on a preponderance of the evidence, the person committing the fault knew that the evidence provided was false or incomplete". No more. A finding of "similar fault" now will be made "if there is *reason to believe*, meaning reasonable grounds to *suspect*, that the person knew the evidence provided was false or incomplete or that the information that was material to the determination was knowingly concealed". "A finding of similar fault requires more than mere suspicion, speculation, or a hunch, but it does not require a preponderance of evidence."

SSA states, "We are revising the evidentiary standard for similar fault from a "preponderance of the evidence" to "reason to believe" to align more closely with the standard provided in the Act". True, the statute does not require a preponderance of the evidence as proof, but rather states that SSA must "immediately redetermine" entitlement or eligibility "if there is reason to believe that fraud or similar fault was involved in the application of the individual for such benefits", and when making an initial determination or a redetermination "shall disregard any evidence if there is reason to believe that fraud or similar fault was involved in the providing of such evidence".

1p defines "fraud" as existing "when a person, with the intent to defraud, either makes or causes to be made, a false statement or misrepresentation of a material fact for use in determining rights under the Act; or conceals or fails to disclose a material fact for use in determining rights under the Act". The definition in 1p for "similar fault" tracks the language of the definition in the statute.

The text in 1p under sec. "A. General" is more expansive than the prior version, providing a little bit of description of some of the circumstances under which an investigation into FSF might be triggered, and may well be worth perusing. Do not, Dear Reader, take this text as a limitation on the Administration's ability to nose into any set of circumstances, however.

A positive change also is introduced in SSR 22-1p. As the Administration states in the preamble in this announcement to the body of the SSR, "We are also providing a new procedure at the hearings level of our administrative review process. The procedure provides that, before we disregard evidence under the Act at the hearings level of our administrative review process, we will consider the individual's objection to the disregarding of that evidence. We expect that these revised procedures will allow us to implement relevant sections of the Act in a manner consistent with the decisions of the Courts of Appeals that have considered legal challenges to the procedures outlined in SSR 16-1p." IOW, having had their hands slapped enough times for tossing out evidence first and not letting the claimant have the FSF determination reviewed, this new SSR provides that, "Together with [an appeal of a denial or unfavorable redetermination], an individual may object to our finding to disregard evidence", and they will consider that on "appeal in accordance with our rules for administrative review". Further, "Before we disregard evidence . . . at the hearings level of our administrative review process, we will consider the individual's objection to the disregarding of that evidence. After considering any objections, our adjudicators will decide whether there is reason to believe that fraud or similar fault was involved in providing evidence in the individual's case." Also, "a finding that there is reason to believe fraud or similar fault was involved in providing evidence does not constitute complete adjudicative action on the redetermination. Even if we disregard evidence, we will evaluate the remaining evidence of record and determine whether that evidence supports a finding of entitlement to benefits or eligibility for payments".

The "in accordance with our rules for administrative review" language also signifies another hand-slapping response by SSA, with the elimination of the language in 16-1p that, "However, we will not administratively review information provided by SSA's Office of the Inspector General under section 1129(l) of the Act regarding its reason to believe that fraud was involved in the individual's application for benefits." No word on whether the file of evidence and musings by OIG actually will be made part of the record, but at least the door is open a crack.

In another positive departure from the prior version of 1p, SSA notes not only that an individual may reapply during the pendency of an appeal of an unfavorable determination even with overlapping periods of entitlement or eligibility, but, expressly, the application must be processed in the regular fashion as [Fn. 3] "SSR 11-1p: Titles II and XVI: Procedures for Handling Requests to File Subsequent Applications for Disability Benefits does not apply in the context of fraud or similar fault redeterminations".

When it comes to SSR 22-2p, sec.s "A" and "B" (definitions) are difficult to distinguish from those in 1p, except that 2p doesn't say much of anything about fraud.

Sec. "C. Development and Evaluation" reminds adjudicators that they have to "consider" all the evidence of record before exploring FSF as to any particular item. Step 2 is to determine "if there is a reason to believe, as defined in this ruling, that similar fault was involved in the provision of evidence." the "reason" may be based on "reasonable inferences" that are "based on all the information in the record". At Step 3, the adjudicator must "fully document the record with the description of the disregarded evidence and the reasons for disregarding" it. The new SSR continues to remind adjudicators that "A similar fault finding cannot be based on speculation or suspicion."

But you don't need me to tell you all about what's in these two SSRs. There is, as always, no substitute for direct familiarity with the actual source, so please see the Fed. Reg. publication. They aren't in SSA's web page with SSRs yet, but you can watch for them there, too. And with that, I bid you happy reading.

-p-

05/04/2022

SSA is extending the Best By dates for Listings Body Systems 2.00 and 102.00, Special Senses and Speech; 7.00 and 107.00, Hematological Disorders; and 10.00 and 110.00, Congenital Disorders That Affect Multiple Body Systems. Last extended, without change, on February 24, 2020, announced at 85 Fed. Reg. 10278, and set to expire June 3, 2022, these body parts have been granted a reprieve until June 5, 2026, unless revised sooner.

The extension is announced in today's Fed. Reg., Vol. 87, No. 86 (Wednesday, May 4, 2022), pp. 26268-26270 available online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2022-09552] --

https://www.govinfo.gov/content/pkg/FR-2022-05-04/html/2022-09552.htm
https://www.govinfo.gov/content/pkg/FR-2022-05-04/pdf/2022-09552.pdf

Trust me, though, Dear Reader, the announcement itself is worth reading only for those concerned about the lack of prior notice and comment period required, subject to certain exceptions, under the Administrative Procedure Act. Suffice it to say, SSA has totted up all its excuses for breaking from the general requirements.

The change in expiration date is not, as of this writing, reflected in the eCFR https://www.ecfr.gov/current/title-20/chapter-III/part-404/subpart-P/appendix-Appendix%201%20to%20Subpart%20P%20of%20Part%20404 , Have no fear, though, Dear Heart, it surely will before this milk sours.

-p-

12/13/2021

SSA has revised the expiration dates for 4 body systems categories in the Listing of Impairments, effective today. Announced in today's Fed. Reg., Vol. 86 (Monday, December 13, 2021), pp. 70728-70729, available online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2021-26884] --

https://www.govinfo.gov/content/pkg/FR-2021-12-13/html/2021-26884.htm
https://www.govinfo.gov/content/pkg/FR-2021-12-13/pdf/2021-26884.pdf

the Listings sections for these body systems that were set by an announcement at 84 Fed. Reg. 64993 (November 26, 2019) to expire February 4, 2022--

Cardiovascular System 4.00 and 104.00
Digestive System 5.00 and 105.00
Skin Disorders 8.00 and 108.00
Immune System Disorders 14.00 and 114.00

now wil expire February 6, 2026.

SSA mentions in the announcement that they published a Notice of Proposed Rulemaking (NPRM) to revise the Listings for Digestive Disorders, 5.00 & 105.00, and for Skin Disorders, 8.00 & 108.00, at 84 Fed. Reg. 35936 (July 25, 2019). No further action on those proposed revisions has been announced in the Fed. Reg.

-p-

11/24/2021

People who undergo a major life-changing event ("LCE") can get their IRMAA reduced. SSA is promulgating new rules to determine what qualifies as a LCE. They want comments from the public. That's you.

Medicare recipients whose MAGI income, on their 1040 income tax return from 2 years ago, exceeds certain incremental thresholds pay extra for their Part B and Part D premiums. The Income Related Monthly Adjusted Amount ("IRMAA") more than triples the amount due for Part B, from the base amount of $170.10 to $578.30, for single 1040 filers with incomes above $499,999, and for married filing jointly (MFJ) filers with incomes above $749,999. The Part D add-on is over 6 times the base amount, from the base of $12.40 to $77.90, for the same filers. While those are big increases, the impact on the purse can be greater for filers whose MAGI is below that big number but still above the minimum. Single filers with MAGI between $91,001 and $114,000 and MFJ between $182,001 and $228,000 pay an additional $68.10 for Part B, and single filers between $114,001 and $142,000, MFJ between $228,001 and $284,000 pay an extra $170.10, for example. See my note from November 15 for more numbers.

In 86 Fed Reg. 66488-66491 (November 23, 2021), SSA announces it seeks comment from the public to guide them in making potential changes that may incorporate being affected by fraud as a ground for reducing IRMAA in individual cases.

IRMAA exists, btw, because the feds want to reduce the amount by which Medicare premiums are subsidized by general tax dollars, for beneficiaries considered financially comfortable enough to be able to afford less of a subsidy. As SSA so redundantly phrases it, "most enrollees pay a monthly premium representing about roughly 25 percent of the estimated actual cost for Part B and the cost of basic prescription drug coverage for Part D." Citations to statutory and regulatory authority, and illustrative narrative explaining the IRMAA program in greater detail, are provided in the Fed. Reg. announcement. The nitty gritty for this particular announcement, however, is that "Beneficiaries who experience a major life-changing event may request that we use information from a more recent tax year to make a new IRMAA determination by completing an SSA-44 (Office of Management and Budget (OMB) No. 0960-0784). Major life-changing events include marriage, divorce or annulment, death of a spouse, work reduction or stoppage, loss of income-producing property, loss of employer pension or receipt of settlement payment from a current or former employer. If a beneficiary provides evidence that a qualifying major life-changing event caused a significant reduction in MAGI, we will determine the IRMAA based on data from a more recent tax year. . . . [citations omitted]"

The revision being being contemplated in this Advance Notice of Proposed Rulemaking (that is to say, no actual proposed regulation has been formulated; this is sort of the focus group stage) would take into account the impact of fraud as a LCE. SSA says this is an important issue because --

"Fraud impacts a greater number of Americans each year and to a greater economic extent. The Federal Trade Commission (FTC) reported receiving more than 2.2 million reports of fraud from consumers, who reported losses of more than $3.3 billion in 2020 (an increase from $1.8 billion in 2019). Just over a third of all consumers who filed a fraud report with the FTC-- 34 percent-- reported losing money, up from 23 percent in 2019. For example, among the increasing reports of fraud, the FTC cites imposter fraud as the number one category of fraud by loss amount. The "imposter fraud" category includes ". . . romance scams, people falsely claiming to be the government, a relative in distress, a well-known business, or a technical support expert, to get a consumer's money." Additionally, as the COVID-19 pandemic continues to impact the United States, the Federal Communications Commission has learned of new scam text-message campaigns and robocalls that prey on virus-related fears, and the FTC has warned against scammers attempting to cash in on confusion relating to COVID-19 vaccines.

"In addition to the above noted new and increased types of fraud, we have also become aware of a significant increase in Social Security number (SSN)-related fraud, and scammers who pose as government employees to defraud unsuspecting victims of their personal information and money. In January 2020, our Inspector General appeared before Congress to address this matter. The Inspector General gave testimony about a significant increase in complaints of callers impersonating Social Security employees or alleging an SSN-related problem. She noted that, in fiscal year (FY) 2018, our Office of the Inspector General (SSA OIG) recorded about 15,000 related complaints, while in FY 2019, the number of such complaints grew to over 478,000. For FY 2020, SSA OIG recorded over 718,000 complaints related to Social Security telephone scams, and in its most recent semiannual report to Congress (for the period of October 1, 2020 through March 31, 2021), SSA OIG reports having received more than 400,000 such complaints during that 6-month period, which would exceed the rate for FY 2020. The FTC reports that Social Security-related phone scams are the most common type of government imposter fraud targeting the public. Recently, the U.S. Attorney's Office for the Northern District of Georgia helped shut down a criminal ring that defrauded the public of over $20 million by impersonating Social Security or IRS employees. We note, however, that Social Security impersonation scams are only one among many types of fraud that could result in income changes that ultimately affect IRMAA amounts. . . .

" Scams, regardless of whether they involve impersonation of SSA employees, may severely harm our beneficiaries in numerous ways, including with respect to our determinations regarding IRMAA. For example, a beneficiary may be defrauded out of a significant amount of money. In addition to losing money, the victim may engage in financial transactions to pay scammers-- such as withdrawing funds from tax-advantaged retirement accounts or liquidating stock-- that increase their MAGI for the year in question. The higher reported income appearing on the victim's tax return can result in an IRMAA assessment or IRMAA increase two years later. [citations omitted] . . ."

For those interested in contributing to the process, please see the full announcement in the Fed. Reg. Your deadline for submitting comments is January 24, 2022.

-p-

11/15/2021

CMS has begun posting Medicare premium and related information for 2022 on its website at https://www.medicare.gov/your-medicare-costs/medicare-costs-at-a-glance and a few other addresses you can get to from that URL.

The Part B monthly premium, likely of greatest interest to the greatest number of people, in 2022 will be
$170.10 up from $148.50 in 2021
The premium rise is capped for lower-amount beneficiaries whose premium payment is deducted before their Social Security benefit arrives, to prevent their DIB or RIB benefit amount from dropping below their 2021 payment level.

For higher-income beneficiaries, the 2022 monthly IRMAA enhancement amounts for Part B and for Part D, based on the MAGI shown on their 2020 tax year income tax return, and differing depending on whether they are INDividual filers, Married Filing Separately (MFS), or Married Filing Jointly (MFJ), are
MAGI IRMAA Premium Part D Add-On
IND /- $500,000 $408.20 $578.30 $77.90

MFJ /= $750,000 $408.20 $578.30 $77.90

MFS /= $409,000 $408.20 $544.30 $77.90

The Part D IRMAA Add-On is payable in addition to whatever the individual Medicare beneficiary's Part D plan's premium happens to be. It's also payable by Part C participants whose Part C plan includes Part D coverage.

The Part B deductible will be $233, up from $203. After a Medicare beneficiary has paid the deductible amount during the year, their subsequent cost liability is limited to 20% or the Medicare-approved amount for doctor services, including when seen in the hospital (with some exceptions), outpatient therapy and durable medical equipment. Part C Medicare participants may see a different cost structure depending on their plan's perks and quirks.

For those who don't automatically have but can buy in to Part A Medicare coverage, the monthly premium in 2022 will be
$499 up from $471 in 2021
but for those with covered earnings for 30 - 39 Quarters of Coverage, the monthly premium will be
$274 up from $259 in 2021

For services covered under Medicare Part A, the inpatient deductible per benefit period, or "spell of illness", in 2022 will be
$1,556 up from $1,484 in 2021
and the daily co-insurance for days 61 - 90 payable will be
$389 up from $371 in 2021
and for days after 90, for a total of 60 days throughout the individual's lifetime (the "lifetime reserve"), the daily co-insurance amount in 2022 will be
$778 up from $742 in 2021

So, what about that Social Security COLA? It was announced October 15, 2021 and officially published at 86 Fed. Reg. 58715 - 58721 October 22, 2021)

The benefit increase is 5.9%. That means the SSI Federal Benefit Rate will be
$841 for an individual and $1,261 for an eligible couple
$421 for a SSI Essential Person
$630.75 for Special Veterans Benefit

The SSI Earned Income Exclusion applicable to students will be $8,230 for the year, up to $2,040 per month.

Rep Payees may take $89 monthly in fees for DA&A beneficiaries and recipients, $48 monthly for others.

The assessment deducted from direct-paid representatives' fees will be $104. That limit goes into effect as of December 1, 2021.

The COLA is tied to inflation as measured by the Consumer Price Index. Certain other threshold amounts applicable to the Social Security system are adjusted according to changes in the National Average Wage Index.

Perhaps of greatest interest in this part of the arena, the Substantial Gainful Activity threshold in 2022 will be
$1,350 for disabled but not blind persons and
2,260 for statutorily blind persons

A Trial Work Period month is accumulated at $970.

A wage-earner accumulates Quarters of Coverage in 2022 to the tune of $1,510, up to $6,040 for the maximum of 4 per calendar year. the Coverage Threshold for domestic workers will be $2,400 in 2022, and for election officials and election workers it will be $2,000.

For RIB beneficiaries, the earnings exemption will be $4,330 per month for those reaching Normal Retirement Age ("NRA") in 2022 (i.e., those born during November, 1955, through August, 1956), and $1,630 per month for RIB beneficiaries ages 62 - NRA.

Various tidbits relating to the calculation of PIA and amount of monthly benefits, and greater depth as to the determination of all of these numbers, also are included in the announcement from SSA. Please see the Fed. Reg. or their website for the nitty gritty.

Now you know.

-p-

09/07/2021

SSA has jettisoned the 5-month disability benefits waiting period for claimants diagnosed with ALS, Amyotrophic Lateral Sclerosis, known also as Lou Gherig's Disease. Announced in 86 Fed. Reg. pp. 48020-48021 (August 27, 2021) --

https://www.govinfo.gov/content/pkg/FR-2021-08-27/html/2021-18435.htm
https://www.govinfo.gov/content/pkg/FR-2021-08-27/pdf/2021-18435.pdf

the change is a final rule, effective August 27, 2021, applicable to claimants whose applications for benefits were approved by SSA on or after July 23, 2020. These regulatory amendments are issued without prior notice and public comment, as they implement amendments to the Social Security Act adopted as the ALS Disability Insurance Access Act of 2019, enacted December 22, 2020, PL 116-250, 134 Stat. 1128, with technical corrections enacted March 23, 2021, PL 117-3, 135 Stat. 246.

As you probably already know, to be found entitled to disability insurance benefits a person must convince SSA that s/he has been or will be unable to do sufficient work for 12 consecutive months, but then benefits are not payable for the first 5 calendar months (amounting to a 6-months-long wait period in practicality for most claimants) since the disability began. It is this 5-month waiting period which now has been waived for claimants who have been diagnosed with ALS. The regulatory changes are pasted below.

-p-

2. Amend Sec. 404.315 by revising paragraph (a)(4) to read as follows:

Sec. 404.315 Who is entitled to disability benefits?
(a) * * *
(4) You have been disabled for 5 full consecutive months or no waiting period is required. The 5-month waiting period begins with a month in which you were both insured for disability and disabled. Your waiting period can begin no earlier than the 17th month before the month you apply--no matter how long you were disabled before then. No waiting period is required if:
(i) You were previously entitled to disability benefits or to a period of disability under Sec. 404.320 any time within 5 years of the month you again became disabled; or
(ii) You have been medically determined to have amyotrophic lateral sclerosis, and we approved your application for disability insurance benefits on or after July 23, 2020.
* * * * *

3. Amend Sec. 404.317 by adding a sentence after the third sentence to
read as follows:

Sec. 404.317 How is the amount of my disability benefit calculated?

* * * If the 5-month waiting period is not required because you have been medically determined to have amyotrophic lateral sclerosis (see Sec. 404.315), your PIA is figured as if you were 62 years old when you become entitled to benefits. * * *

Address

97 Main Street, PO Box 278
East Bloomfield, NY
14443

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+15856576040

Alerts

Be the first to know and let us send you an email when Paul M. Ryther, Attorney at Law posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Paul M. Ryther, Attorney at Law:

Share